In this article, we are going to take a look at where Ideaya Biosciences Inc. (NASDAQ:IDYA) stands against the other NASDAQ stocks. Potomac Wealth Advisors president Mark Avallone joined CNBC's ...
Ideaya Biosciences (IDYA) announced a research collaboration with Attmos as part of its efforts to build a physics-based computational small ...
RBC Capital analyst Gregory Renza maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) yesterday and set a price target of $57.00. The company’s shares closed yesterday at ...
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a US-based medicine oncology company, on Friday, 2025 announced that, its Compensation Committee granted non-qualified stock options for 125,600 shares ...